BHR Biosynex Proudly Debuts Revolutionary RevDx Portable Full Blood Count POCT System at Clinical Innovations Expo 2025
BHR Biosynex has today unveiled the RevDx portable full blood count POCT system at the Clinical Innovations Expo in Nottingham, marking its first-ever appearance in the UK. Developed by Israeli medtech innovators EfA Technologies, RevDx offers clinicians rapid, lab-quality haematology results using just a drop of blood, directly at the point of care. This compact device has the potential to transform diagnostics across both primary and remote settings. We are joined at the Expo by Yoel Ezra, founder and CEO of EfA, and are actively seeking feedback and partnerships with UK healthcare providers for evaluation studies.
